Leadership

Michael founded Francis Medical in 2018, serving as a Director and Chief Technology Officer. He recently completed the VAPOR2 Pivotal Study for Vanquish prostate cancer treatment.

Before Francis, Michael co-founded NxThera to develop and commercialize the urology applications of the vapor platform technology he invented and sold the Rezum device to Boston Scientific.

Before becoming an entrepreneur, Michael taught in several departments and performed research at the University of Minnesota, including the Department of Physiology, the Department of Urologic Surgery in the School of Medicine, the Institute of Technology, and at the Carlson School of Management. 

Professor Hoey also taught in the Department of Biological Sciences at Hamline University in St. Paul, Minnesota. He is an expert in the interaction of thermotherapy and tissue and a prolific inventor, with over 300 patents applied for and/or granted – the majority of which are in the medical device field. Michael’s inventions include platform technologies which form the foundation for products being sold, or in development for, various cardiac surgery, oncology, orthopedic, pulmonology, general surgery, urology, gynecology, and vascular surgery applications. Michael has been a consultant to, as well as a founder and principal of, several medical products companies, which have collectively raised over $400 million in capital.